Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phosphotransferases (Alcohol Group Acceptor) | 6 | 2015 | 201 | 1.370 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 8 | 2011 | 147 | 0.870 |
Why?
|
| Receptors, Lysosphingolipid | 5 | 2016 | 63 | 0.820 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 7 | 2011 | 150 | 0.820 |
Why?
|
| Insulin-Like Growth Factor II | 3 | 2011 | 52 | 0.770 |
Why?
|
| Lysophospholipids | 6 | 2016 | 209 | 0.750 |
Why?
|
| Receptor, IGF Type 2 | 3 | 2011 | 13 | 0.720 |
Why?
|
| Sphingosine | 6 | 2016 | 315 | 0.720 |
Why?
|
| Enzyme Activation | 7 | 2015 | 791 | 0.640 |
Why?
|
| MAP Kinase Signaling System | 5 | 2012 | 247 | 0.530 |
Why?
|
| Transcriptional Activation | 3 | 2012 | 226 | 0.530 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2007 | 110 | 0.510 |
Why?
|
| Calcium Channels | 1 | 2015 | 59 | 0.500 |
Why?
|
| Mesangial Cells | 2 | 2012 | 37 | 0.490 |
Why?
|
| Calcium | 3 | 2016 | 929 | 0.420 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2012 | 76 | 0.400 |
Why?
|
| Type C Phospholipases | 1 | 2011 | 67 | 0.390 |
Why?
|
| Protein Kinase C | 1 | 2011 | 270 | 0.360 |
Why?
|
| Up-Regulation | 2 | 2012 | 682 | 0.350 |
Why?
|
| Lipoproteins, LDL | 1 | 2012 | 343 | 0.340 |
Why?
|
| Angiotensin II | 4 | 2015 | 220 | 0.320 |
Why?
|
| HEK293 Cells | 6 | 2016 | 326 | 0.310 |
Why?
|
| ErbB Receptors | 2 | 2010 | 239 | 0.290 |
Why?
|
| Signal Transduction | 9 | 2019 | 2689 | 0.280 |
Why?
|
| Paracrine Communication | 2 | 2019 | 31 | 0.280 |
Why?
|
| Somatomedins | 1 | 2006 | 16 | 0.280 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2013 | 80 | 0.280 |
Why?
|
| Arrestins | 4 | 2013 | 92 | 0.260 |
Why?
|
| Hypertension | 1 | 2015 | 1535 | 0.260 |
Why?
|
| Phenylalanine | 1 | 2004 | 22 | 0.240 |
Why?
|
| Rats | 9 | 2016 | 5300 | 0.240 |
Why?
|
| Povidone | 1 | 2004 | 12 | 0.230 |
Why?
|
| Cell Transplantation | 1 | 2004 | 22 | 0.230 |
Why?
|
| Cryoprotective Agents | 1 | 2004 | 31 | 0.230 |
Why?
|
| Proteins | 1 | 2007 | 474 | 0.230 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 87 | 0.220 |
Why?
|
| Cryopreservation | 1 | 2004 | 103 | 0.220 |
Why?
|
| Cell Membrane | 3 | 2015 | 525 | 0.220 |
Why?
|
| Animals | 13 | 2019 | 20881 | 0.200 |
Why?
|
| Protein Transport | 2 | 2012 | 280 | 0.190 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2012 | 376 | 0.180 |
Why?
|
| RNA Interference | 3 | 2011 | 266 | 0.180 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2011 | 42 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2015 | 2083 | 0.160 |
Why?
|
| Green Fluorescent Proteins | 2 | 2011 | 200 | 0.160 |
Why?
|
| Phosphorylation | 5 | 2011 | 1200 | 0.160 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2011 | 138 | 0.160 |
Why?
|
| Osteoblasts | 1 | 2019 | 99 | 0.150 |
Why?
|
| Osteogenesis | 1 | 2019 | 152 | 0.150 |
Why?
|
| Transcriptome | 1 | 2019 | 164 | 0.150 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2016 | 18 | 0.140 |
Why?
|
| Cell Line | 5 | 2008 | 1752 | 0.140 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 113 | 0.140 |
Why?
|
| RNA, Small Interfering | 3 | 2012 | 434 | 0.130 |
Why?
|
| Humans | 15 | 2016 | 68618 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1034 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2015 | 235 | 0.120 |
Why?
|
| Protein Phosphatase 2 | 2 | 2011 | 67 | 0.120 |
Why?
|
| GTP-Binding Proteins | 2 | 2013 | 231 | 0.110 |
Why?
|
| Protein Isoforms | 2 | 2012 | 246 | 0.110 |
Why?
|
| Vasoconstrictor Agents | 2 | 2011 | 107 | 0.110 |
Why?
|
| Kallikreins | 2 | 2013 | 323 | 0.110 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2013 | 75 | 0.110 |
Why?
|
| Insulin | 2 | 2007 | 619 | 0.100 |
Why?
|
| Maleimides | 1 | 2011 | 15 | 0.100 |
Why?
|
| Enzyme Activators | 1 | 2011 | 14 | 0.100 |
Why?
|
| Protein Kinase C beta | 1 | 2011 | 19 | 0.100 |
Why?
|
| Diglycerides | 1 | 2011 | 49 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2012 | 137 | 0.100 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2011 | 37 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2012 | 98 | 0.090 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 63 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 196 | 0.090 |
Why?
|
| Receptor, PAR-2 | 1 | 2010 | 7 | 0.090 |
Why?
|
| Indoles | 1 | 2011 | 146 | 0.090 |
Why?
|
| Receptor, PAR-1 | 1 | 2010 | 30 | 0.090 |
Why?
|
| Diabetic Nephropathies | 1 | 2012 | 161 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2015 | 1330 | 0.090 |
Why?
|
| Mice | 4 | 2019 | 8474 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2012 | 2673 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2015 | 1451 | 0.080 |
Why?
|
| Receptors, Adiponectin | 1 | 2008 | 10 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 332 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 317 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 2791 | 0.080 |
Why?
|
| Lysosomes | 1 | 2009 | 136 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2009 | 220 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1664 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1174 | 0.070 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2006 | 6 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 322 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 562 | 0.060 |
Why?
|
| Receptors, Somatomedin | 1 | 2004 | 7 | 0.060 |
Why?
|
| Tyrphostins | 1 | 2004 | 13 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 167 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2004 | 67 | 0.060 |
Why?
|
| beta-Arrestins | 3 | 2011 | 80 | 0.060 |
Why?
|
| Pharmaceutic Aids | 1 | 2004 | 7 | 0.060 |
Why?
|
| Quinazolines | 1 | 2004 | 70 | 0.060 |
Why?
|
| Thiophenes | 1 | 2004 | 76 | 0.060 |
Why?
|
| Endocytosis | 1 | 2004 | 113 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2004 | 30 | 0.060 |
Why?
|
| Nitrogen | 1 | 2004 | 57 | 0.060 |
Why?
|
| Glycerol | 1 | 2004 | 26 | 0.060 |
Why?
|
| Tyrosine | 1 | 2004 | 196 | 0.060 |
Why?
|
| Cytoskeleton | 1 | 2004 | 84 | 0.060 |
Why?
|
| Aorta | 2 | 2016 | 316 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2019 | 320 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1293 | 0.050 |
Why?
|
| Temperature | 1 | 2004 | 341 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 618 | 0.050 |
Why?
|
| Glucose | 1 | 2004 | 307 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 498 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2019 | 53 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2019 | 124 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2019 | 37 | 0.040 |
Why?
|
| Bone Remodeling | 1 | 2019 | 45 | 0.040 |
Why?
|
| Male | 2 | 2015 | 37321 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 94 | 0.040 |
Why?
|
| Bone Density | 1 | 2019 | 159 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2016 | 122 | 0.030 |
Why?
|
| Biological Transport | 1 | 2016 | 210 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 4655 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 493 | 0.030 |
Why?
|
| Losartan | 1 | 2013 | 45 | 0.030 |
Why?
|
| Allosteric Site | 1 | 2013 | 17 | 0.030 |
Why?
|
| Dimerization | 1 | 2013 | 99 | 0.030 |
Why?
|
| Ligands | 1 | 2013 | 317 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 144 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2011 | 26 | 0.020 |
Why?
|
| Histone Chaperones | 1 | 2011 | 11 | 0.020 |
Why?
|
| beta-Arrestin 1 | 1 | 2011 | 22 | 0.020 |
Why?
|
| Cyclooxygenase 1 | 1 | 2011 | 29 | 0.020 |
Why?
|
| beta-Arrestin 2 | 1 | 2011 | 29 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 57 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 64 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 85 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2010 | 18 | 0.020 |
Why?
|
| ADAM17 Protein | 1 | 2010 | 28 | 0.020 |
Why?
|
| EGF Family of Proteins | 1 | 2010 | 17 | 0.020 |
Why?
|
| Amphiregulin | 1 | 2010 | 19 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 238 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2011 | 110 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2010 | 53 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2013 | 705 | 0.020 |
Why?
|
| Benzamides | 1 | 2011 | 156 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2011 | 178 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 146 | 0.020 |
Why?
|
| Piperazines | 1 | 2011 | 206 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1745 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 238 | 0.020 |
Why?
|
| Adiponectin | 1 | 2008 | 52 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2008 | 91 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2007 | 7 | 0.020 |
Why?
|
| raf Kinases | 1 | 2007 | 6 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 34 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 468 | 0.020 |
Why?
|
| ras Proteins | 1 | 2008 | 102 | 0.020 |
Why?
|
| Cell Division | 1 | 2008 | 541 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 700 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2011 | 753 | 0.020 |
Why?
|
| Base Sequence | 1 | 2008 | 1015 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 742 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 1851 | 0.020 |
Why?
|
| Cytosol | 1 | 2006 | 123 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2006 | 305 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 694 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 981 | 0.010 |
Why?
|